At Delta4 we’re always looking for key partnerships that are mutually beneficial. Combining our strengths with those of your pharmaceutical company, university, research organization, etc. we can accelerate progress and accomplish more together.
Delta4 is a leading biotech company specializing in AI-powered drug discovery and repurposing. Our powerful in-silico platform, Hyper-C, efficiently discovers undetected relationships between drugs with a known safety profile and diseases to identify new indications. Delta4 is able to help in the following areas:
It’s an honor and a privilege to be working with the best of the best!
Scientist.com provides a unique platform where researchers and suppliers can both find each other and work together more easily. They provide a collaboration framework to streamline the typically long and tedious process of defining the terms and conditions of an agreement.
Members can work together smoothly and effortlessly by agreeing to the rules of the platform. The result is that together we can achieve the results we need faster.
“Delta4’s AI-Powered Hyper-C Platform Uncovers New Drug Indications, Expanding Treatment Potential for Iguratimod” – As Featured on Scientist.com
